Forward Pharma A/S (FWPAY)
Forward Pharma A/S operates in the Biotechnology industry of the Healthcare sector, headquartered in Copenhagen, DK. The stock last traded at $300.00, down 25.09% on the session, giving a market capitalisation of $7.4M. On trailing twelve-month figures it carries a trailing P/E of -3.88, a net margin of 0.0%. Its beta of 1.02 implies it has historically moved more than the broad market.
Forward Pharma A/S currently conducts no significant business activities. In its prior operations, the company functioned as a biopharmaceutical firm. It dedicated its efforts to advancing FP187, its exclusive formulation of dimethyl fumarate, designed to address inflammatory and neurological disorders. Forward Pharma A/S was founded in 2005 and maintains its corporate headquarters in Copenhagen, Denmark.
Forward Pharma A/S is most often compared with the following Healthcare names: